Cryo-Cell International Current Assets

Cryo-Cell International (CCEL) currently reports a current assets of $13M as of August 2026. That compares with $12M in the prior-year period — up 12.8% year over year. Use the charts on this page to explore Cryo-Cell International's current assets history and peer comparisons.

Cryo-Cell International's current assets increased from $12M to $13M — a 12.8% year-over-year increase (period ending August 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cryo-Cell International reported $13M in current assets as of August 2026. That compares with $12M in the prior-year period — up 12.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cryo-Cell International, and consider following CCEL for alerts when major investors trade the stock.

Cryo-Cell International is classified in the Healthcare sector. On current assets, it currently shows $13M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CCEL with unrelated industries.